DK0805813T3 - Tricyclic vasopressin antagonists - Google Patents
Tricyclic vasopressin antagonistsInfo
- Publication number
- DK0805813T3 DK0805813T3 DK96902143T DK96902143T DK0805813T3 DK 0805813 T3 DK0805813 T3 DK 0805813T3 DK 96902143 T DK96902143 T DK 96902143T DK 96902143 T DK96902143 T DK 96902143T DK 0805813 T3 DK0805813 T3 DK 0805813T3
- Authority
- DK
- Denmark
- Prior art keywords
- vasopressin antagonists
- tricyclic
- tricyclic vasopressin
- antagonists
- vasopressin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/373,125 US5521173A (en) | 1995-01-17 | 1995-01-17 | Tricyclic benzazepine vasopressin antagonists |
PCT/US1996/000515 WO1996022292A1 (fr) | 1995-01-17 | 1996-01-16 | Antagonistes de vasopressine tricycliques |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0805813T3 true DK0805813T3 (da) | 2002-08-05 |
Family
ID=23471074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96902143T DK0805813T3 (da) | 1995-01-17 | 1996-01-16 | Tricyclic vasopressin antagonists |
Country Status (24)
Country | Link |
---|---|
US (2) | US5521173A (fr) |
EP (1) | EP0805813B1 (fr) |
JP (2) | JP4156664B2 (fr) |
CN (1) | CN1052725C (fr) |
AR (1) | AR002021A1 (fr) |
AT (1) | ATE217625T1 (fr) |
AU (1) | AU707881B2 (fr) |
BR (1) | BR9607177A (fr) |
CA (1) | CA2210708C (fr) |
CZ (1) | CZ224797A3 (fr) |
DE (1) | DE69621225T2 (fr) |
DK (1) | DK0805813T3 (fr) |
EA (1) | EA000056B1 (fr) |
ES (1) | ES2175066T3 (fr) |
HK (1) | HK1003891A1 (fr) |
HU (1) | HUP9702459A3 (fr) |
IL (1) | IL116774A (fr) |
MX (1) | MX9705414A (fr) |
NZ (1) | NZ301198A (fr) |
PT (1) | PT805813E (fr) |
TW (1) | TW472056B (fr) |
UA (1) | UA48960C2 (fr) |
WO (1) | WO1996022292A1 (fr) |
ZA (1) | ZA96303B (fr) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5736540A (en) * | 1993-07-29 | 1998-04-07 | American Cyanamid Company | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
US5700796A (en) * | 1995-01-17 | 1997-12-23 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
US5753648A (en) * | 1995-01-17 | 1998-05-19 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
US5880122A (en) * | 1996-11-01 | 1999-03-09 | American Home Products Corporation | 3-Carboxamide derivatives of 5H-pyrrolo 2,1-c! 1,4!-benzodiazepines |
EP0987266A4 (fr) * | 1997-03-31 | 2000-07-26 | Wakamoto Pharma Co Ltd | Derives de biphenyle et compositions medicinales |
US6194407B1 (en) | 1997-07-30 | 2001-02-27 | American Home Products Corporation | Tricyclic pyrido vasopressin agonists |
RU2213094C2 (ru) * | 1997-07-30 | 2003-09-27 | Американ Хоум Продактс Корпорейшн | Трициклические соединения, способы их получения, фармацевтическая композиция и способ лечения |
US6511974B1 (en) | 1997-07-30 | 2003-01-28 | Wyeth | Tricyclic vasopressin agonists |
US7138393B2 (en) * | 1998-07-24 | 2006-11-21 | Wyeth | Biologically active vasopressin agonist metabolites |
US6090803A (en) * | 1998-07-24 | 2000-07-18 | American Home Products Corporation | Tricyclic vasopressin agonists |
DE69911259D1 (de) * | 1999-01-19 | 2003-10-16 | Ortho Mcneil Pharm Inc | Tricyclische benzodiazepine als vasopressin antagonisten |
US6235900B1 (en) | 1999-02-04 | 2001-05-22 | American Home Products Corporation | Tricyclic pyridine N-oxides vasopressin agonists |
US6344451B1 (en) | 1999-02-04 | 2002-02-05 | American Home Products | Pyrrolobenzodiazepine carboxyamide vasopressin agonists |
US6297234B1 (en) * | 1999-02-04 | 2001-10-02 | American Home Products Corporation | Arylthiophene vasopressin agonists |
EP1149103A1 (fr) * | 1999-02-04 | 2001-10-31 | American Home Products Corporation | Thienylbenzoylbenzazepines utilisees en tant qu'agonistes de la vasopressine |
US6620807B1 (en) | 1999-02-04 | 2003-09-16 | Wyeth | Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists |
CN1391476A (zh) * | 1999-09-27 | 2003-01-15 | 美国氰胺公司 | 血管升压素激动剂制剂和方法 |
ATE394371T1 (de) * | 2001-03-20 | 2008-05-15 | Serono Lab | Pyrrolidinesterderivate mit oxytocinmodulierender wirkung |
US7202239B2 (en) * | 2001-04-12 | 2007-04-10 | Wyeth | Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists |
US6903087B2 (en) * | 2001-04-12 | 2005-06-07 | Wyeth | Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
JP2004526771A (ja) * | 2001-04-12 | 2004-09-02 | ワイス | シクロヘキシルフェニルバソプレッシンアゴニスト |
US7109193B2 (en) | 2001-04-12 | 2006-09-19 | Wyeth | Tricyclic diazepines tocolytic oxytocin receptor antagonists |
US6900200B2 (en) * | 2001-04-12 | 2005-05-31 | Wyeth | Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
US6977254B2 (en) * | 2001-04-12 | 2005-12-20 | Wyeth | Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
US7326700B2 (en) * | 2001-04-12 | 2008-02-05 | Wyeth | Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
US6903091B2 (en) * | 2001-04-12 | 2005-06-07 | Wyeth | Biphenyl vasopressin agonists |
US7064120B2 (en) * | 2001-04-12 | 2006-06-20 | Wyeth | Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
US7022699B2 (en) * | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
PL370114A1 (en) * | 2001-10-29 | 2005-05-16 | Ortho-Mcneil Pharmaceutical, Inc. | Bridged bicycle (1,4) benzodiazepine vasopressin receptor antagonists |
US7119088B2 (en) * | 2003-02-19 | 2006-10-10 | Pfizer Inc. | Triazole compounds useful in therapy |
EP2061795B1 (fr) * | 2006-08-14 | 2014-01-15 | Council of Scientific & Industrial Research | Hybrides pyrrolo[2,1-c][1,4]benzodiazépine et leur procédé de préparation |
CN102118968A (zh) | 2008-06-10 | 2011-07-06 | 雅培制药有限公司 | 新的三环化合物 |
JP5567027B2 (ja) | 2008-11-13 | 2014-08-06 | エフ.ホフマン−ラ ロシュ アーゲー | スピロ−5,6−ジヒドロ−4H−2,3,5,10b−テトラアザ−ベンゾ[e]アズレン |
PL2358714T3 (pl) | 2008-11-18 | 2012-12-31 | Hoffmann La Roche | Etery alkilocykloheksylowe dihydrotetraazabenzoazulenu |
NZ592076A (en) | 2008-11-28 | 2012-06-29 | Hoffmann La Roche | Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists |
WO2011068899A1 (fr) | 2009-12-01 | 2011-06-09 | Abbott Laboratories | Nouveaux composés tricycliques |
KR20170118230A (ko) | 2009-12-01 | 2017-10-24 | 애브비 인코포레이티드 | 신규한 트리사이클릭 화합물 |
US8420633B2 (en) | 2010-03-31 | 2013-04-16 | Hoffmann-La Roche Inc. | Aryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8461151B2 (en) | 2010-04-13 | 2013-06-11 | Hoffmann-La Roche Inc. | Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes |
US8492376B2 (en) | 2010-04-21 | 2013-07-23 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8481528B2 (en) | 2010-04-26 | 2013-07-09 | Hoffmann-La Roche Inc. | Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US9199976B2 (en) | 2010-06-01 | 2015-12-01 | The University Of Queensland | Haematopoietic-prostaglandin D2 synthase inhibitors |
CN103288829A (zh) * | 2012-02-24 | 2013-09-11 | 中国科学院大连化学物理研究所 | 一种合成手性二氢-5H-吡咯并[2,1-c][1,4]-苯并二氮杂卓-5-酮的方法 |
WO2014060381A1 (fr) | 2012-10-18 | 2014-04-24 | Bayer Cropscience Ag | Composés hétérocycliques pour la lutte contre les nuisibles |
CN104884449A (zh) | 2012-10-31 | 2015-09-02 | 拜尔农作物科学股份公司 | 作为害虫防治剂的新的杂环化合物 |
US10202356B2 (en) | 2013-03-14 | 2019-02-12 | Tolero Pharmaceuticals, Inc. | JAK2 and ALK2 inhibitors and methods for their use |
US11512092B2 (en) | 2015-10-16 | 2022-11-29 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
SG11201802990RA (en) | 2015-10-16 | 2018-05-30 | Abbvie Inc | PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF |
US11365198B2 (en) | 2015-10-16 | 2022-06-21 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US10550126B2 (en) | 2015-10-16 | 2020-02-04 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11524964B2 (en) | 2015-10-16 | 2022-12-13 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11773106B2 (en) | 2015-10-16 | 2023-10-03 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
JP2021530554A (ja) | 2018-07-26 | 2021-11-11 | スミトモ ダイニッポン ファーマ オンコロジー, インコーポレイテッド | 異常なacvr1発現を伴う疾患を処置するための方法およびそこで使用するためのacvr1阻害剤 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3763183A (en) * | 1972-07-10 | 1973-10-02 | Sterling Drug Inc | 1,2,3,10,11,11a-hexahydro-5h-pyrrolo (2,1-c)(1,4)benzodiazepines |
US4766108A (en) * | 1986-12-04 | 1988-08-23 | Smith Kline Beckman Corporation | Tyr-Arg-vasopressin antagonists |
US5055448A (en) * | 1987-06-25 | 1991-10-08 | Medical College Of Ohio | Linear derivatives of arginine vasopressin antagonists |
ES2056259T3 (es) * | 1989-02-10 | 1994-10-01 | Otsuka Pharma Co Ltd | Derivados de carboestirilo. |
US5258510A (en) * | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
WO1991005549A1 (fr) * | 1989-10-20 | 1991-05-02 | Otsuka Pharmaceutical Co., Ltd. | Composes benzoheterocycliques |
US5070187A (en) * | 1989-11-03 | 1991-12-03 | Trustees Of Boston University | Pharmacologically effective antagonists of arginine-vasopressin |
TW199153B (fr) * | 1990-08-07 | 1993-02-01 | Dtsuka Seiyaku Kk | |
TW198715B (fr) * | 1991-04-19 | 1993-01-21 | Dtsuka Seiyaku Kk | |
EP0533242A3 (en) * | 1991-09-16 | 1993-09-15 | Merck & Co. Inc. | Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
US5204349A (en) * | 1991-09-16 | 1993-04-20 | Merck & Co., Inc. | Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
DE69223573D1 (de) * | 1991-09-16 | 1998-01-29 | Merck & Co Inc | Hydantoin und Succinimid-substituierte Spiroindanylcamphorsulfonyl als Oxytocin-Antagonisten |
EP0533240A3 (en) * | 1991-09-16 | 1993-09-29 | Merck & Co. Inc. | Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
TW250481B (fr) * | 1992-08-20 | 1995-07-01 | Otsuka Pharma Co Ltd | |
WO1994012476A1 (fr) * | 1992-11-25 | 1994-06-09 | Yamanouchi Pharmaceutical Co., Ltd. | Derive de benzanilide |
WO1994014796A1 (fr) * | 1992-12-21 | 1994-07-07 | Yamanouchi Pharmaceutical Co., Ltd. | Nouveau derive de n-(pyridylcarbonyl)benzazepine et son intermediaire |
WO1994020473A1 (fr) * | 1993-03-11 | 1994-09-15 | Yamanouchi Pharmaceutical Co., Ltd. | Compose avec action antagoniste de la vasopressine |
GB9307527D0 (en) * | 1993-04-13 | 1993-06-02 | Fujisawa Pharmaceutical Co | New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
US5516774A (en) * | 1993-07-29 | 1996-05-14 | American Cyanamid Company | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
-
1995
- 1995-01-17 US US08/373,125 patent/US5521173A/en not_active Expired - Lifetime
-
1996
- 1996-01-15 ZA ZA96303A patent/ZA96303B/xx unknown
- 1996-01-15 AR ARP960101024A patent/AR002021A1/es unknown
- 1996-01-16 CZ CZ972247A patent/CZ224797A3/cs unknown
- 1996-01-16 WO PCT/US1996/000515 patent/WO1996022292A1/fr not_active Application Discontinuation
- 1996-01-16 AT AT96902143T patent/ATE217625T1/de not_active IP Right Cessation
- 1996-01-16 PT PT96902143T patent/PT805813E/pt unknown
- 1996-01-16 IL IL11677496A patent/IL116774A/xx not_active IP Right Cessation
- 1996-01-16 AU AU46566/96A patent/AU707881B2/en not_active Ceased
- 1996-01-16 UA UA97084248A patent/UA48960C2/uk unknown
- 1996-01-16 JP JP52234496A patent/JP4156664B2/ja not_active Expired - Fee Related
- 1996-01-16 CA CA002210708A patent/CA2210708C/fr not_active Expired - Fee Related
- 1996-01-16 DE DE69621225T patent/DE69621225T2/de not_active Expired - Fee Related
- 1996-01-16 CN CN96192570A patent/CN1052725C/zh not_active Expired - Fee Related
- 1996-01-16 MX MX9705414A patent/MX9705414A/es not_active IP Right Cessation
- 1996-01-16 EP EP96902143A patent/EP0805813B1/fr not_active Expired - Lifetime
- 1996-01-16 ES ES96902143T patent/ES2175066T3/es not_active Expired - Lifetime
- 1996-01-16 TW TW085100471A patent/TW472056B/zh not_active IP Right Cessation
- 1996-01-16 BR BR9607177A patent/BR9607177A/pt not_active IP Right Cessation
- 1996-01-16 DK DK96902143T patent/DK0805813T3/da active
- 1996-01-16 HU HU9702459A patent/HUP9702459A3/hu unknown
- 1996-01-16 NZ NZ301198A patent/NZ301198A/xx unknown
- 1996-01-16 EA EA199700118A patent/EA000056B1/ru not_active IP Right Cessation
- 1996-05-23 US US08/652,198 patent/US5780471A/en not_active Expired - Lifetime
-
1998
- 1998-04-16 HK HK98103196A patent/HK1003891A1/xx not_active IP Right Cessation
-
2007
- 2007-11-21 JP JP2007301897A patent/JP2008069176A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EA199700118A1 (ru) | 1997-12-30 |
CA2210708A1 (fr) | 1996-07-25 |
US5521173A (en) | 1996-05-28 |
BR9607177A (pt) | 1997-11-11 |
EP0805813B1 (fr) | 2002-05-15 |
DE69621225D1 (de) | 2002-06-20 |
NZ301198A (en) | 1999-08-30 |
HUP9702459A2 (hu) | 1998-05-28 |
ES2175066T3 (es) | 2002-11-16 |
UA48960C2 (uk) | 2002-09-16 |
AR002021A1 (es) | 1998-01-07 |
CZ224797A3 (cs) | 1998-03-18 |
AU707881B2 (en) | 1999-07-22 |
HK1003891A1 (en) | 1998-11-13 |
TW472056B (en) | 2002-01-11 |
HUP9702459A3 (en) | 2000-08-28 |
JP2008069176A (ja) | 2008-03-27 |
EA000056B1 (ru) | 1998-04-30 |
PT805813E (pt) | 2002-10-31 |
MX9705414A (es) | 1997-11-29 |
ZA96303B (en) | 1997-07-15 |
EP0805813A1 (fr) | 1997-11-12 |
ATE217625T1 (de) | 2002-06-15 |
IL116774A0 (en) | 1996-05-14 |
JPH11500424A (ja) | 1999-01-12 |
CN1052725C (zh) | 2000-05-24 |
DE69621225T2 (de) | 2002-11-14 |
IL116774A (en) | 2000-12-06 |
AU4656696A (en) | 1996-08-07 |
CN1178532A (zh) | 1998-04-08 |
WO1996022292A1 (fr) | 1996-07-25 |
US5780471A (en) | 1998-07-14 |
JP4156664B2 (ja) | 2008-09-24 |
CA2210708C (fr) | 2005-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE217625T1 (de) | Tricyclische vasopressin antagonisten | |
DK0804438T3 (da) | Tricycliske benzazepin-vasopressinantagonister | |
BR9606977A (pt) | Antagonistas de vasopressina de benzazepina triciclica | |
DE69826487D1 (de) | Trizyclische vasopressin agoniste | |
ATE381570T1 (de) | Trizyclische benzazepin-vasopressin-antagoniste | |
BR9710087A (pt) | Antagonistas de vasopressina de benzazepina tricíclicos | |
DK0738150T3 (da) | Bicykliske fibrinogene antagonister | |
NO972016D0 (no) | Indolyl-Y-reseptorantagonister | |
DE69719354D1 (de) | Muscarin-antagonisten | |
IS4664A (is) | Ný peptíð-ópíóíð | |
DE69203955T2 (de) | Benzazepinderivate als Vasopressin-Antagonisten. | |
ATE251166T1 (de) | Bicyclische benzazepin-derivate als vasopressin- antagonisten | |
PT964867E (pt) | Antagonistas da taquicinima | |
EE04318B1 (et) | Parendatud toimega LHRH antagonistid | |
FI98053B (fi) | Sekoitus | |
KR960029102U (ko) | 가족 납골묘 | |
DE29507124U1 (de) | Bügel-Kombinationsschloß | |
KR970020767U (ko) | 세면기 고정받침대 | |
BR9612155A (pt) | Mistura | |
IT236758Y1 (it) | Alpestock multiuso | |
KR970020545U (ko) | 조합식 반지 | |
DE29515065U1 (de) | Waschtischkombination | |
UA25947C2 (uk) | Міhhий загороджувач | |
KR970023848U (ko) | 메인스위치 잠금장치 |